In this regard, Shih et al described that BRCA1 and BRCA2 germline mutations were twice as common in individuals developing a second non-ovarian carcinoma, with follicular thyroid carcinoma being one of the most frequent secondary tumours [18]. The gene discussed is BRCA1; the disease is ovarian carcinoma.